Tempsens Instruments jumps 17% as stock extends IPO gains
In short
Tempsens Instruments shares rose 17% on Tuesday and traded about 89% above their ₹300 IPO price. The company also reported first-half FY27 revenue growth of 33.7% year on year, but margins fell to 21.2%.
Investors seem to like the growth, but higher employee costs and expansion spending hurt profits. It is not stated in the available reporting whether the stock can keep rising.
What the reporting says
Tempsens Instruments shares surged 17% on Tuesday and were about 89% above the ₹300 IPO price, according to the publisher summary. First-half FY27 revenue rose 33.7% year on year, but higher employee costs and expansion spending cut EBITDA margins to 21.2% from 25.2%. The immediate market reaction was positive, while the reporting leaves the sustainability of the rally and the full demand picture unclear.
Why it matters
Tempsens Instruments shares surged 17% on Tuesday, extending gains to about 89% above the ₹300 IPO price. The publisher summary says first-half FY27 revenue rose 33.7% year on year, but higher employee costs and expansion investments reduced EBITDA margins to 21.2% from 25.2%. The stock move looks supported by revenue growth, but the margin pressure leaves the durability of the rally uncertain.